✦ LIBER ✦

Comparison of cefoperazone sodium vs methicillin, ticarcillin, and tobramycin in treatment of pulmonary exacerbations in patients with cystic fibrosis

✍ Scribed by Catherine V. Jewett; Joel Ledbetter; Raymond K. Lyrene; Dana M. Brasfield; Ralph E. Tiller

Book ID: 119461243
Publisher: Elsevier Science
Year: 1985
Tongue: English
Weight: 346 KB
Volume: 106
Category: Article
ISSN: 1097-6833
DOI: 10.1016/s0022-3476(85)80100-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ceftazidime in treatment of acute pulmon

Ceftazidime in treatment of acute pulmonary exacerbations in patients with cystic fibrosis

✍ Rita Padoan; Antonio Brienza; Rosa M. Crossignani; Giorgio Lodi; Annamaria Giunt 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 410 KB

Ceftazidime plus tobramycin, twice vs th

Ceftazidime plus tobramycin, twice vs thrice daily in the treatment of respiratory exacerbations in adult cystic fibrosis patients

✍ A. Jones; D. Adeboyeku; M. Hodson 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Treatment of pulmonary infections in pat

Treatment of pulmonary infections in patients with cystic fibrosis: A comparative study of ticarcillin and gentamicin

✍ Michael F. Parry; Harold C. Neu; Mario Merlino; Pureza Flor Gaerlan; Celia N. Or 📂 Article 📅 1977 🏛 Elsevier Science 🌐 English ⚖ 442 KB

180 Choice of IV vs. non-IV antibiotics

180 Choice of IV vs. non-IV antibiotics for treating pulmonary exacerbations in patients with cystic fibrosis

✍ J.S. Wagener; D.R. VanDevanter; W. Regelmann; L. Rasouliyan; W.J. Morgan; D.J. P 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Comparison of flutter device and chest p

Comparison of flutter device and chest physical therapy in the treatment of cystic fibrosis pulmonary exacerbation

✍ Magdalen Gondor; Patricia A. Nixon; Rebecca Mutich; Paul Rebovich; David M. Oren 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 2 views

Chest physiotherapy (CPT) is recommended for the clearance of bronchial secretions in the management of patients with cystic fibrosis (CF). The Flutter® valve (Scandipharm, Birmingham, AL) has been introduced as an alternative method to CPT for airway mucus clearance. The objective of this study was

Evaluation of long term tobramycin thera

Evaluation of long term tobramycin therapy in patients with cystic fibrosis and advanced pulmonary disease

✍ U. Paporisz; H. G. Posselt; R. Wönne; W. Ristow; D. Röser; H. Knothe; S. W. Bend 📂 Article 📅 1979 🏛 Springer 🌐 English ⚖ 493 KB

To nine cystic fibrosis patients with chronic bronchopulmonary infection of severely damaged lungs invaded by Pseudomonas aeruginosa, eleven courses of prolonged tobramycin treatment (5 mg/kg/day) for four to 16 weeks were administered. Pulmonary symptoms improved and a better quality of life was ac